Pancreatic Cancer section

Prostate Cancer News & Features

Drinking Wine in Moderation Does Not Appear to Impact Prostate Cancer Risk

Drinking Wine in Moderation Does Not Appear to Impact Prostate Cancer Risk

Interestingly, red and white wine to not affect prostate cancer risk the same way.

USPSTF: Decision to Undergo PSA Screening Should Be Individual

USPSTF: Decision to Undergo PSA Screening Should Be Individual

The decision to undergo periodic PSA screening for prostate cancer should be an individual one for men aged 55 to 69 years, according to the recommendation statement.

Lower Disease-Specific Mortality Seen With Early Detection of Prostate Cancer

Lower Disease-Specific Mortality Seen With Early Detection of Prostate Cancer

In an analysis of data from the SEER program, researchers determined that early detection of prostate cancer has let to an improvement in the number of men presenting with metastatic prostate cancer.

Challenges of Shared Decision Making in Prostate Cancer Screening

Challenges of Shared Decision Making in Prostate Cancer Screening

A review of shared decision making with men about undergoing PSA testing revealed that although full SDM discussions are increasing, variations in whether these discussions occur and how much information is shared still exist.

Long-term Prostate Cancer Risk Reduction Seen With Finasteride

Long-term Prostate Cancer Risk Reduction Seen With Finasteride 

Finasteride recipients had a 21.1% decreased risk of prostate cancer compared with placebo recipients, researchers found.

PSA Screening Increases Prostate Cancer Detection, No Significant Difference in Mortality

PSA Screening Increases Prostate Cancer Detection, No Significant Difference in Mortality

Researchers conducted a randomized clinical study of men to determine the impact of PSA screening on prostate cancer detection and mortality.

Following False-Positive Results, Patients More Likely to Have Future Cancer Screenings

Following False-Positive Results, Patients More Likely to Have Future Cancer Screenings

The researchers found that the choice to undergo future screenings appeared to be influenced by previous false-positive results for both men and women.

Taxane Acute Pain Syndrome in Cancer Therapy: Occurrence, Impact on Quality of Life

Taxane Acute Pain Syndrome in Cancer Therapy: Occurrence, Impact on Quality of Life

Results of a prospective study of patients with breast or prostate cancer demonstrate the impact of taxane-based chemotherapy on quality of life.

Increased Monitoring Increases Cost, Not Quality of Care or Survival, in Prostate Cancer

Increased Monitoring Increases Cost, Not Quality of Care or Survival, in Prostate Cancer

In an evaluation of SEER-Medicare data, researchers sought to determine the benefits of extreme use of monitoring in patients with metastatic prostate cancer at the end of life on survival outcomes, quality of life, and costs.

Promising Phase 2 Results Lead to Fast Track Designation for Pancreatic Cancer Drug

Promising Phase 2 Results Lead to Fast Track Designation for Pancreatic Cancer Drug 

FDA Fast Track designation was supported by data from a Phase 2 study reviewing pamrevlumab in combination with gemcitabine and nab-paclitaxel.

Prostate Cancer Resources

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs